Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group
- 15 July 2003
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (14) , 2726-2731
- https://doi.org/10.1200/jco.2003.11.036
Abstract
Purpose: To assess the efficacy and toxicity of chemotherapy alone in patients older than 60 years with primary CNS lymphoma.Keywords
This publication has 20 references indexed in Scilit:
- CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin’s lymphomaInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS LymphomaJournal of Clinical Oncology, 2000
- Primary central nervous system non-hodgkin’s lymphoma (PCNSL): survival advantages with combined initial therapy? a final report of the north central cancer treatment group (NCCTG) study 86-72-52International Journal of Radiation Oncology*Biology*Physics, 1999
- Primary central nervous system lymphoma: age and performance status are more important than treatment modalityInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Long-term survival in primary CNS lymphoma.Journal of Clinical Oncology, 1998
- Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?Cancer, 1997
- Epidemiology of Brain Lymphoma Among People With or Without Acquired Immunodeficiency SyndromeJNCI Journal of the National Cancer Institute, 1996
- The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression [see comments]Blood, 1995
- Combined modality therapy for primary CNS lymphoma.Journal of Clinical Oncology, 1992
- Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315International Journal of Radiation Oncology*Biology*Physics, 1992